The Effect of Bifid Triple Viable on Immune Function of Patients with Ulcerative Colitis
Autor: | Guohua Li, Sheng Zeng, Wangdi Liao, Nonghua Lv |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2012 |
Předmět: | |
Zdroj: | Gastroenterology Research and Practice, Vol 2012 (2012) |
Druh dokumentu: | article |
ISSN: | 1687-6121 1687-630X |
DOI: | 10.1155/2012/404752 |
Popis: | Objective. To study effect and its mechanism of Bifid Triple Viable for initially treating ulcerative colitis with 5-aminosalicylic acid. Methods. 82 patients, who were firstly diagnosed as ulcerative colitis, were randomized into experiment group (41 cases, treated with Bifid Triple Viable and Etiasa) and control group (41 cases, treated with Etiasa). The clinic symptom score, colon mucosa inflammation score, and some immune indices were detected and compared between two groups before and two months after treatment. Results. Two months after treatment, the clinical symptom score, colon mucosa inflammation score, and IL-1β expression in colon mucosa decreased significantly (P |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |